BlackRock Portfolio Management LLC - Mar 31, 2025 SCHEDULE 13G Report for Stoke Therapeutics, Inc. Common Stock (STOK)

Filing Manager: BlackRock Portfolio Management LLC
Reporting Manager: BlackRock Portfolio Management LLC
Security: Stoke Therapeutics, Inc. Common Stock
Symbol: STOK
Shares outstanding: 53.8M shares
Disclosed Ownership: 2.74M shares
Ownership: 5.1%
Form type: SCHEDULE 13G
Date filed: 4/15/2025, 05:04 PM
Date of event: Mar 31, 2025
Next filing: Jul 15, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock Portfolio Management LLC	5.1%	2.74M	2.61M	0	Spencer Fleming	Managing Director